3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Biphenotypic, Acute
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Leukemia, Myeloid, Accelerated Phase
4
Blast Crisis
4
Down Syndrome
3
Myelodysplastic Syndromes
2
Lymphoma, Mantle-Cell
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Urinary Bladder Neoplasms
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Primary Myelofibrosis
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Mouth Neoplasms
1
Medulloblastoma
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Carcinoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Magnetic Resonance Spectroscopy
8
X-Rays
7
Phantoms, Imaging
7
Cyclophosphamide
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
fludarabine
4
Etoposide
4
Biopsy
4
tazemetostat
3
etoposide phosphate
3
Vincristine
3
Temozolomide
3
Nivolumab
3
Cisplatin
3
Carboplatin
3
Automobiles
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Topotecan
2
Sirolimus
2
Methotrexate
2
Mesna
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
merphos
×
1 year
×
Clear all
No trials found.